Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Ob/Gyn Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Ob/Gyn Other
    Blood Test Can Reduce Repeat Breast MRI in Women With Irregular Menstrual Cycles - (DGNews)
    Flibanserin Provides Multiple Benefits in Women With Low Sexual Desire: Presented at ESSM - (DGDispatch)
    ACOG Recommends Pap Tests for Cervical Cancer Screening Begin Later, With Lower Frequency - (DGNews)
    Flibanserin Effectively Treats Women With Low Libido: Presented at ESSM - (DGDispatch)
    US Panel Ups Age for Routine Breast Cancer Screening From 40 to 50 - (DGNews)

    News archive

     Recent webcasts/CME - Ob/Gyn Other
    • Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future
    • Taking Stock of the Current Research: Which New Therapies Are Showing Promise in Ovarian Cancer?
    • Q&A Lightning Round: Expert Opinions on Unanswered Questions and Controversies in Ovarian Cancer
    • Update on DVT and PE in OB Gyn/Ortho Patients
      Hypoactive Sexual Desire Disorder in Women: Implications for Family Practice

      Webcasts/CME archive

       Recent cases - Ob/Gyn Other
        Effects of Growth Hormone Reduction in a Patient with Polycystic Ovary Syndrome Complicated with Acromegaly
        Endometriosis Presenting as an Acute Groin Swelling: A Case Report
        Giant Ovarian Serous Cystadenoma in a Postmenopausal Woman: A Case Report
        Failure of Ultrasound to Diagnose a Giant Ovarian Cyst: A Case Report
        Female Sexual Dysfunction

        Cases archive
          




        my personal edition > ob/gyn other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Fluconazole, Itraconazole Equally Effective In Vulvovaginal Candidiasis

        A DGReview of :"Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study."
        European Journal of Obstetrics & Gynecology and Reproductive Biology

        02/07/2003
        By Anne MacLennan


        Both fluconazole and itraconazole produce dramatic results within one week in women with acute vulvovaginal candidiasis (VVC), suggest researchers in Italy.

        This study, from three university centres, found that each of the two oral antifungal agents showed good clinical and mycological efficacy on the acute VVC episode, achieving significant decrease of signs and symptoms after seven days of treatment.

        Led by Dr C De Punzio from the Universita degli Studi di Pisa, these investigators compared safety and efficacy of fluconazole 150mg single dose and itraconazole 200mg per day for three days in 86 patients.

        All of the patients in the double-blind randomised study had acute clinically and mycologically confirmed VVC. Of the 86, a total of 70 -- 38 on fluconazole and 32 on itraconazole -- were able to be evaluated.

        By day 7, all but one of the fluconazole patients were cured or improved, and there was eradication of the baseline pathogen in all but two patients on itraconazole. At day 21, a 13% relapse rate was observed in both groups, with all other patients cured or improved and eradication rates of 76% for fluconazole and 66% for itraconazole.

        Although global symptom scores (GSS) were significantly more severe at baseline in fluconazole patients, the slope of the GSS decrease between baseline and day seven was similar for both groups and, on the last visit, GSS were identical.

        As for adverse events, 19 fluconazole patients reported 31, and 15 itraconazole patients reported 30.

        The authors point out fluconazole in single dose warrants optimal compliance in patients who frequently experience more than one episode of VVC.
        Eur J Obstet Gynecol Reprod Biol 2003 Feb;106:2:193-7. "Fluconazole 150 mg single dose versus itraconazole 200 mg per day for 3 days in the treatment of acute vaginal candidiasis: a double-blind randomized study."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send